407 related articles for article (PubMed ID: 7585040)
1. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein.
Malhotra R; Wormald MR; Rudd PM; Fischer PB; Dwek RA; Sim RB
Nat Med; 1995 Mar; 1(3):237-43. PubMed ID: 7585040
[TBL] [Abstract][Full Text] [Related]
2. Glycobiology: 'the function of sugar in the IgG molecule'.
Dwek RA; Lellouch AC; Wormald MR
J Anat; 1995 Oct; 187 ( Pt 2)(Pt 2):279-92. PubMed ID: 7591992
[TBL] [Abstract][Full Text] [Related]
3. Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis.
Cuchacovich M; Gatica H; Grigg DM; Pizzo SV; Gonzalez-Gronow M
J Rheumatol; 1996 Jan; 23(1):44-51. PubMed ID: 8838507
[TBL] [Abstract][Full Text] [Related]
4. Agalactosyl IgG and mannose-binding proteins: biochemical nicety or pathophysiological paradigm?
Ezekowitz RA
Nat Med; 1995 Mar; 1(3):207-8. PubMed ID: 7585032
[No Abstract] [Full Text] [Related]
5. Lectin-carbohydrate interactions in disease. T-cell recognition of IgA and IgD; mannose binding protein recognition of IgG0.
Rudd P; Fortune F; Lehner T; Parekh R; Patel T; Wormald M; Malhotra R; Sim R; Dwek R
Adv Exp Med Biol; 1995; 376():147-52. PubMed ID: 8597241
[TBL] [Abstract][Full Text] [Related]
6. Isotype and glycoform selection for antibody therapeutics.
Jefferis R
Arch Biochem Biophys; 2012 Oct; 526(2):159-66. PubMed ID: 22465822
[TBL] [Abstract][Full Text] [Related]
7. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
[TBL] [Abstract][Full Text] [Related]
8. Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity.
Krapp S; Mimura Y; Jefferis R; Huber R; Sondermann P
J Mol Biol; 2003 Jan; 325(5):979-89. PubMed ID: 12527303
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis.
Bond A; Cooke A; Hay FC
Eur J Immunol; 1990 Oct; 20(10):2229-33. PubMed ID: 2242757
[TBL] [Abstract][Full Text] [Related]
10. Altered glycan accessibility on native immunoglobulin G complexes in early rheumatoid arthritis and its changes during therapy.
Stümer J; Biermann MHC; Knopf J; Magorivska I; Kastbom A; Svärd A; Janko C; Bilyy R; Schett G; Sjöwall C; Herrmann M; Muñoz LE
Clin Exp Immunol; 2017 Sep; 189(3):372-382. PubMed ID: 28509333
[TBL] [Abstract][Full Text] [Related]
11. IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation.
Jefferis R; Lund J; Pound JD
Immunol Rev; 1998 Jun; 163():59-76. PubMed ID: 9700502
[TBL] [Abstract][Full Text] [Related]
12. Immunology. Sugar determines antibody activity.
Burton DR; Dwek RA
Science; 2006 Aug; 313(5787):627-8. PubMed ID: 16888131
[No Abstract] [Full Text] [Related]
13. Mannan binding lectin and its interaction with immunoglobulins in health and in disease.
Arnold JN; Dwek RA; Rudd PM; Sim RB
Immunol Lett; 2006 Aug; 106(2):103-10. PubMed ID: 16814399
[TBL] [Abstract][Full Text] [Related]
14. Fucosylation of IgG heavy chains is increased in rheumatoid arthritis.
Gornik I; Maravić G; Dumić J; Flögel M; Lauc G
Clin Biochem; 1999 Nov; 32(8):605-8. PubMed ID: 10638942
[TBL] [Abstract][Full Text] [Related]
15. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Wright A; Morrison SL
J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
[TBL] [Abstract][Full Text] [Related]
16. Impaired binding capacity of asialyl and agalactosyl IgG to Fc gamma receptors.
Adler Y; Lamour A; Jamin C; Menez JF; Le Corre R; Shoenfeld Y; Youinou P
Clin Exp Rheumatol; 1995; 13(3):315-9. PubMed ID: 7554557
[TBL] [Abstract][Full Text] [Related]
17. Carbamylation reduces the capacity of IgG for hexamerization and complement activation.
Lubbers R; Oostindie SC; Dijkstra DJ; Parren PWHI; Verheul MK; Abendstein L; Sharp TH; de Ru A; Janssen GMC; van Veelen PA; van den Bremer ETJ; Bleijlevens B; de Kreuk BJ; Beurskens FJ; Trouw LA
Clin Exp Immunol; 2020 Apr; 200(1):1-11. PubMed ID: 31853959
[TBL] [Abstract][Full Text] [Related]
18. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy.
Alavi A; Arden N; Spector TD; Axford JS
J Rheumatol; 2000 Jun; 27(6):1379-85. PubMed ID: 10852257
[TBL] [Abstract][Full Text] [Related]
19. Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity.
Nimmerjahn F; Anthony RM; Ravetch JV
Proc Natl Acad Sci U S A; 2007 May; 104(20):8433-7. PubMed ID: 17485663
[TBL] [Abstract][Full Text] [Related]
20. A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation.
Lund J; Tanaka T; Takahashi N; Sarmay G; Arata Y; Jefferis R
Mol Immunol; 1990 Nov; 27(11):1145-53. PubMed ID: 2174119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
